Viewing Study NCT04187560


Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2026-06-26 @ 4:06 AM
Study NCT ID: NCT04187560
Status: COMPLETED
Last Update Posted: 2020-12-10
First Post: 2019-11-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy Adults
Sponsor: LB Pharmaceuticals Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: LB-102-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators